ArticleAccountability in research2020
Survey of equal contributions in biomedical research publications.
Article in Accountability in research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Ordering matters in shared authorship: a response to Decius and Schilbach.Scientometrics · 2025Article
- Authorship best practices in biophysics.Biophysical journal · 2023Article
- Shared first authorship should be declared on academic CVs.Nature human behaviour · 2023Article
- Authorship Issues When Articles are Retracted Due to Research Misconduct and Then Resubmitted.Science and engineering ethics · 2022Article
- Academic Promotion of Physicians in Medical Schools: A Special Focus on Primary Health Care in Taiwan.International journal of environmental research and public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We conducted a cross-sectional survey of 1,540 researchers concerning their experiences with and attitudes toward the ethics of equal contribution (EC) designations in publications. Over half the respondents (58.3%) said they had been designated as an EC at least once. Although most respondents agreed that EC designations can be a useful way of promoting collaborations (81.7%) or resolving disagreements about authorship order (63.3%), a substantial proportion of respondents (38.1%) regarded these designations as useful but ethically questionable. 31.7% of respondents said EC designations are ethically questionable because ECs are difficult to define or measure and 25.9% said they are ethically questionable because people rarely contribute equally. Most respondents (71.8%) agreed that it is unfair to name two people as ECs when they have not contributed equally and that journals (73.4%), research teams (69.5%), and research institutions (63%) should develop policies concerning EC designations. Views concerning the ethics and policies of EC designations were influenced by the race/ethnicity and position of respondents but not by gender. Researchers who had been designated as ECs were less likely to regard this practice as ethically questionable than those who had not.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.